Aphria (NYSE:APHA) Stock Price Up 5.3%
Aphria Inc (NYSE:APHA) rose 5.3% during trading on Wednesday . The company traded as high as $6.65 and last traded at $6.58, approximately 4,221,539 shares were traded during mid-day trading. A decline of 24% from the average daily volume of 5,564,664 shares. The stock had previously closed at $6.25.
APHA has been the subject of a number of recent analyst reports. ValuEngine upgraded Aphria from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. CIBC downgraded Aphria from a “neutral” rating to a “sector underperform” rating in a report on Friday, July 26th. Zacks Investment Research upgraded Aphria from a “hold” rating to a “buy” rating and set a $8.00 price objective for the company in a report on Wednesday, August 7th. Finally, Jefferies Financial Group initiated coverage on Aphria in a report on Friday, May 24th. They issued a “buy” rating and a $11.00 price objective for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $13.63.
The firm has a fifty day simple moving average of $6.37 and a 200-day simple moving average of $7.89. The company has a market capitalization of $1.65 billion, a P/E ratio of -59.82 and a beta of 3.07.
Several institutional investors have recently made changes to their positions in APHA. Two Sigma Advisers LP bought a new stake in shares of Aphria in the fourth quarter worth about $129,000. Bank of America Corp DE bought a new stake in shares of Aphria in the fourth quarter worth about $2,175,000. Legal & General Group Plc bought a new stake in shares of Aphria in the fourth quarter worth about $297,000. Norges Bank bought a new stake in shares of Aphria in the fourth quarter worth about $10,301,000. Finally, Deutsche Bank AG bought a new stake in shares of Aphria in the fourth quarter worth about $960,000. Institutional investors own 8.46% of the company’s stock.
Aphria Company Profile (NYSE:APHA)
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: How is a price target determined?
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.